UltraPlasma™ Multi-Plasma Systems for Chickenpox Rash Treatment

Introduction

Chickenpox (varicella) is a viral infection characterized by itchy, blister-like rashes on the skin. Although it typically resolves within 7–10 days, the acute inflammation, vesicle rupture, and subsequent risk of scarring or secondary bacterial infections require supportive interventions. UltraPlasma™, a next-generation dermatological device, uses arc, argon, and helium plasma technologies with precisely tuned software and hardware-controlled emission spectrums, offering a non-invasive, sterilizing, and regenerative solution.

1. UltraPlasma Multi-Platform Plasma Emission and Custom Spectrum Control

The UltraPlasma™ system integrates:

• UltraPlasma™ arc plasma mode (blue-white): Delivers concentrated thermal and electrical energy, ideal for cauterizing ruptured vesicles and promoting clotting.

• UltraPlasma™ argon plasma mode (blue-violet): Generates stable low-temperature plasma ideal for microbial inactivation and tissue regeneration.

• UltraPlasma™ helium plasma mode (violet): Enables deep skin penetration with minimal thermal damage, ideal for immune modulation and pain relief.

Its proprietary software modulates:

• Frequency, voltage, pulse width

• Gas mix ratios (O₂, O₃, NO, He, Ar)

• Waveform patterns customized for chickenpox lesion morphology

2. Effects on Epidermis, Dermis, and Hypodermis

Epidermis

• Disinfection of ruptured vesicles via ozone and NO interaction

• Reduction of keratinocyte inflammation

• Acceleration of epithelial closure without scarring

Dermis

• UltraPlasma™ argon plasma mode stimulates fibroblast activation and collagen synthesis

• NO gas promotes vasodilation and improved microcirculation

• Reduction of secondary inflammation and hyperpigmentation

Hypodermis

• UltraPlasma™ helium plasma mode enhances lymphatic drainage

• Modulates adipose-resident immune cells

• Supports systemic immune response and reduces prolonged viral inflammation

3. Reactive Gas Dynamics in Plasma Treatment

4. Clinical Outcomes: Before and After UltraPlasma™ Treatment

• Day 0: Multiple papules and vesicles with erythema

• Day 1: Vesicle drying, scab formation, reduced itching

• Day 3-5: Epithelial regeneration, no secondary infections, scar prevention

⌘Conclusion⌘

UltraPlasma™ presents a powerful therapeutic modality for chickenpox by:

• Reducing acute viral load and inflammation,

• Promoting rapid dermal healing,

• Minimizing scarring and post-viral complications.

The combination of specially moded arc, argon, and helium plasmas within a digitally controlled emission system allows patient-specific treatment protocols, ensuring both safety and efficacy.

Shortcut for our Goals!

▼